Literature DB >> 8645680

The role of angiogenesis in the spread of oral squamous cell carcinoma.

C N Penfold1, M Partridge, R Rojas, J D Langdon.   

Abstract

Microvessels were counted in 41 primary oral squamous cell carcinomas using JC70 antibody to PECAM (CD31). The counts were compared with clinical and pathological indicators of tumour behaviour including lymph node status, tumour stage, type of histological differentiation, size and velocity of tumour growth. Tumour microvessel counts correlated with lymph node metastasis (p < 0.001). This association was independent of tumour size, velocity and type of histological differentiation and when all the variables were analysed by multivariate analysis only vascular count showed a significant association with lymph node metastasis.

Entities:  

Mesh:

Year:  1996        PMID: 8645680     DOI: 10.1016/s0266-4356(96)90133-3

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  14 in total

1.  Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients.

Authors:  Alexander Darom; Ilias P Gomatos; Emmanuel Leandros; Emmu Chatzigianni; Dimitris Panousopoulos; Manousos M Konstadoulakis; George Androulakis
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

2.  Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation.

Authors:  A Giatromanolaki; G Fountzilas; M I Koukourakis; P Arapandoni; V Theologi; S Kakolyris; V Georgoulias; A L Harris; K C Gatter
Journal:  Clin Exp Metastasis       Date:  1998-10       Impact factor: 5.150

3.  Histomorphometric Analysis of Angiogenesis using CD31 Immunomarker and Mast Cell Density in Oral Premalignant and Malignant Lesions: A Pilot Study.

Authors:  M Jyothsna; M Rammanohar; Kiran Kumar
Journal:  J Clin Diagn Res       Date:  2017-01-01

4.  Inhibitory effect of angiogenesis inhibitor TNP-470 on human ACHN renal cell carcinoma.

Authors:  Jin Zeng; Wei Mei; Haipeng Huang; Xiaodong Li; Peng Kong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

5.  Angiogenesis in oral squamous cell carcinoma.

Authors:  G Ascani; P Balercia; M Messi; L Lupi; G Goteri; A Filosa; D Stramazzotti; T Pieramici; C Rubini
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-02       Impact factor: 2.124

6.  Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma.

Authors:  Panayiotis A Kyzas; Dimitrios Stefanou; Anna Batistatou; Niki J Agnantis
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

7.  Combination Cancer Therapy of a Del1 Fragment and Cisplatin Enhanced Therapeutic Efficiency In Vivo.

Authors:  Hisataka Kitano; Yoh Masaoka; Atsushi Mamiya; Yusuke Fujiwara; Toshio Miki; Chiaki Hidai
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

8.  Size, shape, structure, and direction of angiogenesis in laryngeal tumour development.

Authors:  J Laitakari; V Näyhä; F Stenbäck
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

9.  Significance of neo-angiogenesis and immuno-surveillance cells in squamous cell carcinoma of the tongue.

Authors:  Juma O Alkhabuli
Journal:  Libyan J Med       Date:  2007-03-01       Impact factor: 1.657

10.  VEGF: A critical driver for angiogenesis and subsequent tumor growth: An IHC study.

Authors:  Prakhar Kapoor; Rs Deshmukh
Journal:  J Oral Maxillofac Pathol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.